Search

Author/Creator Loftus, Edward V

72. The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission. (May 2023)

Authors:
Burisch, Johan; Zhao, Mirabella; Odes, Selwyn; De Cruz, Peter; Vermeire, Severine; Bernstein, Charles N; Kaplan, Gilaad G; Duricova, Dana; Greenberg, Dan; Melberg, Hans O; Watanabe, Mamoru; Ahn, Hyeong Sik; Targownik, Laura; Pittet, Valérie E H; Annese, Vito; Park, KT; Katsanos, Konstantinos H; H...
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 8:Number 5(2023)
Page Start:
458
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

73. The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota. Issue 4 (29th November 2006)

Authors:
Pardi, Darrell S; Loftus, Edward V; Smyrk, Thomas C; Kammer, Patricia P; Tremaine, William J; Schleck, Cathy D; Harmsen, W Scott; Zinsmeister, Alan R; Melton, L Joseph; Sandborn, William J
Journal:
Gut
Issue:
Volume 56:Issue 4(2007)
Page Start:
504
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

74. The Impact of Vedolizumab on Pre-Existing Extraintestinal Manifestations of Inflammatory Bowel Disease: A Multicenter Study. Issue 8 (9th November 2020)

Authors:
Ramos, Guilherme Piovezani; Dimopoulos, Christina; McDonald, Nicholas M; Janssens, Laurens P; Hung, Kenneth W; Proctor, Deborah; Ruggiero, Elizabeth; Kane, Sunanda; Bruining, David H; Faubion, William A; Raffals, Laura E; Loftus, Edward V; Al-Bawardy, Badr
Journal:
Inflammatory bowel diseases
Issue:
Volume 27:Issue 8(2021)
Page Start:
1270
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

76. The Real‐World Effectiveness and Safety of Vedolizumab for Moderate–Severe Crohn's Disease: Results From the US VICTORY Consortium. (August 2016)

Authors:
Dulai, Parambir S; Singh, Siddharth; Jiang, Xiaoqian; Peerani, Farhad; Narula, Neeraj; Chaudrey, Khadija; Whitehead, Diana; Hudesman, David; Lukin, Dana; Swaminath, Arun; Shmidt, Eugenia; Wang, Shuang; Boland, Brigid S; Chang, John T; Kane, Sunanda; Siegel, Corey A; Loftus, Edward V; Sandborn, Wi...
Journal:
American journal of gastroenterology
Issue:
Volume 111:Number 8(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

77. The safety of vedolizumab for ulcerative colitis and Crohn's disease. Issue 5 (18th February 2016)

Authors:
Colombel, Jean-Frédéric; Sands, Bruce E; Rutgeerts, Paul; Sandborn, William; Danese, Silvio; D'Haens, Geert; Panaccione, Remo; Loftus, Edward V; Sankoh, Serap; Fox, Irving; Parikh, Asit; Milch, Catherine; Abhyankar, Brihad; Feagan, Brian G
Journal:
Gut
Issue:
Volume 66:Issue 5(2017)
Page Start:
839
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

78. Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Infection Rates from the Ulcerative Colitis Clinical Programme. (27th November 2020)

Authors:
Winthrop, Kevin L; Loftus, Edward V; Baumgart, Daniel C; Reinisch, Walter; Nduaka, Chudy I; Lawendy, Nervin; Chan, Gary; Mundayat, Rajiv; Friedman, Gary S; Salese, Leonardo; Thorpe, Andrew J; Su, Chinyu
Journal:
Journal of Crohn's and colitis
Issue:
Volume 15:Number 6(2021)
Page Start:
914
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

79. Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Nonmelanoma Skin Cancer Rates From the Ulcerative Colitis Clinical Program. Issue 2 (1st February 2022)

Authors:
Sands, Bruce E; Long, Millie D; Reinisch, Walter; Panés, Julian; Loftus, Edward V; Nduaka, Chudy I; Soonasra, Arif; Mundayat, Rajiv; Lawendy, Nervin; Chan, Gary; Friedman, Gary S; Su, Chinyu
Journal:
Inflammatory bowel diseases
Issue:
Volume 28:Issue 2(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

80. Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Nonmelanoma Skin Cancer Rates From the Ulcerative Colitis Clinical Program. Issue 2 (20th March 2021)

Authors:
Sands, Bruce E; Long, Millie D; Reinisch, Walter; Panés, Julian; Loftus, Edward V; Nduaka, Chudy I; Soonasra, Arif; Mundayat, Rajiv; Lawendy, Nervin; Chan, Gary; Friedman, Gary S; Su, Chinyu
Journal:
Inflammatory bowel diseases
Issue:
Volume 28:Issue 2(2022)
Page Start:
234
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗